Emess Biosciences Limited
Emess Biosciences Limited
#06944607 • Active
Founded: 25/06/2009
Industries: Management consultancy activities other than financial management
Location: Flat 1 55 Portland Place, London, W1B 1QL, England
Financial Snapshot
Last accounts made up to 30 June 2024
Next accounts due 31 March 2026 (10 months)
Total Liabilities £62,491
↓ -66%
Employees 2
↑ 0%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Penelope Kay Sinclair | Company Director | 01/03/2018 | British | 79 years |
| Michael Jeffrey Sinclair | Co Director | 25/06/2009 | British,israeli | 82 years |
Role:
Company Director
Appointed:
01/03/2018
Nationality:
British
Age:
79 years
Role:
Co Director
Appointed:
25/06/2009
Nationality:
British,israeli
Age:
82 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Michael Jeffrey Sinclair | Significant Influence Or Control | 01/07/2016 | British |
Michael Jeffrey Sinclair
Nature of Control:
Significant Influence Or Control
Notified On:
01/07/2016
Nationality:
British
Financial Accounts
| Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
1 charge registered
Resolve Invest Limited Outstanding
Created 20/10/2017#069446070001 Negative Pledge
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 18/11/2024 | Accounts | Accounts With Accounts Type Total Exemption Full | View (10 pages) |
| 12/07/2024 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 11/04/2024 | Accounts | Accounts With Accounts Type Total Exemption Full | View (11 pages) |
| 10/07/2023 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 02/12/2022 | Address | Change Registered Office Address Company With Date Old Address New Address | View (1 page) |
| 16/09/2022 | Accounts | Accounts With Accounts Type Total Exemption Full | View (8 pages) |
| 29/06/2022 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
02/12/2022 Address
Change Registered Office Address Company With Date Old Address New Address